Insider: Bhatia Sangeeta N. Director - VERTEX PHARMACEUTICALS INC / MA
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 4,565 | 0 | 4,565 |
| Value | $1,743,236.55 | $0.00 | $1,743,236.55 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/27/2025 | DDS | 266 | Direct | COM | $386.69 | $102,859.54 | 4,565 |
| 05/02/2025 | DDS | 400 | Direct | COM | $505.86 | $202,344.00 | 4,831 |
| 08/30/2024 | DDS | 646 | Direct | COM | $500.00 | $323,000.00 | 4,435 |
| 08/08/2024 | DDS | 1,292 | Direct | COM | $466.29 | $602,446.68 | 4,435 |
| 05/02/2024 | DDS | 467 | Direct | COM | $402.95 | $188,177.65 | 4,435 |
| 10/17/2023 | DDS | 243 | Direct | COM | $375.00 | $91,125.00 | 3,901 |
| 10/06/2023 | DDS | 242 | Direct | COM | $360.00 | $87,120.00 | 4,144 |
| 08/09/2023 | DDS | 242 | Direct | COM | $345.51 | $83,613.42 | 4,386 |
| 05/02/2023 | DDS | 62 | Direct | COM | $345.93 | $21,447.66 | 5,146 |
| 05/02/2023 | DDS | 172 | Direct | COM | $346.69 | $59,630.68 | 4,974 |
| 05/02/2023 | DDS | 163 | Direct | COM | $349.82 | $57,020.66 | 4,691 |
| 05/02/2023 | DDS | 63 | Direct | COM | $351.20 | $22,125.60 | 4,628 |
| 05/02/2023 | DDS | 120 | Direct | COM | $348.16 | $41,779.20 | 4,854 |
| 10/24/2022 | DDS | 621 | Direct | COM | $310.00 | $192,510.00 | 4,040 |
| 08/08/2022 | DDS | 47 | Direct | COM | $295.53 | $13,889.91 | 4,661 |
| 08/08/2022 | DDS | 45 | Direct | COM | $290.18 | $13,058.10 | 5,237 |
| 08/08/2022 | DDS | 164 | Direct | COM | $291.76 | $47,848.64 | 5,073 |
| 08/08/2022 | DDS | 161 | Direct | COM | $294.24 | $47,372.64 | 4,708 |
| 08/08/2022 | DDS | 204 | Direct | COM | $293.15 | $59,802.60 | 4,869 |
| 07/29/2022 | DDS | 200 | Direct | COM | $277.95 | $55,590.00 | 5,604 |
| 07/29/2022 | DDS | 99 | Direct | COM | $276.65 | $27,388.35 | 5,804 |
| 07/29/2022 | DDS | 160 | Direct | COM | $279.28 | $44,684.80 | 5,444 |
| 07/29/2022 | DDS | 58 | Direct | COM | $281.03 | $16,299.74 | 5,287 |
| 07/29/2022 | DDS | 99 | Direct | COM | $280.22 | $27,741.78 | 5,345 |
| 07/29/2022 | DDS | 5 | Direct | COM | $282.34 | $1,411.70 | 5,282 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research